Agenda in progress 🛠️ 
 Our agenda is currently a work in progress and will be refined over the coming weeks. 
In the meantime, you can already explore the key session themes that will shape the conference and its discussions. Stay tuned for the full agenda and speaker details coming soon.

Day 1 

Programme 26th March

Foyer
Mar 26, 2026
12:30 PM1:15 PM

Arrival and registration

Introduction Innovation for competitiveness: Driving adoption of AI-based digital medical devices

Main stage - C1
Mar 26, 2026
1:15 PM1:20 PM

Introduction

Main stage - C1
Mar 26, 2026
1:20 PM1:30 PM

Welcome address

Main stage - C1
Mar 26, 2026
1:30 PM1:45 PM

Opening speech

LD
Lex Delles
Minister of the Economy, SMEs, Energy and Tourism
Main stage - C1
Mar 26, 2026
1:45 PM2:00 PM

Keynote address

Session 1:  Need-driven innovation of digital medical devices: Addressing real challenges

While digital medical devices — particularly those powered by AI — raise new expectations of enhanced healthcare system efficiency and care transformation, many yet struggle to gain traction. Why? Because they fail to address the real, unmet needs of patients, healthcare professionals and health systems. This session explores how healthtech innovators can identify and qualify genuine clinical and operational needs in order to translate them into innovations with solid value propositions.
Main stage - C1
Mar 26, 2026
2:00 PM2:15 PM

AI technologies in healthcare: Hype or hope?

Main stage - C1
Mar 26, 2026
2:15 PM2:30 PM

Needs-driven innovation: How to create your toolbox

Main stage - C1
Mar 26, 2026
2:30 PM3:20 PM

Round table – Responding to multiple stakeholder needs: Is AI accelerating or adding complexity?

Foyer
Mar 26, 2026
3:20 PM3:45 PM

Coffee break

Session 2:  Medical Device Regulation and AI Act: Leveraging value of innovation

Navigating complex regulations can be challenging for healthtech innovators — but as a gatekeeper of quality and safety, EU regulations are a powerful proof of the reliability and trustworthiness of digital medical devices. Leveraging on the ongoing MDR revision and the implementation of the AI Act, this session discusses how to turn evidence-based development and regulatory compliance into value that will result in a market advantage, and explores how regulators can uphold high standards without hindering innovation.
Main stage - C1
Mar 26, 2026
3:45 PM4:00 PM

Medical Device Regulation revision: Boost or barrier to market access and global competitiveness?

Main stage - C1
Mar 26, 2026
4:00 PM4:15 PM

Valuing AI in medical devices: A common challenge for regulators and innovators

Main stage - C1
Mar 26, 2026
4:15 PM5:05 PM

Round table – Digital medical devices: Is the EU still attractive for a first market launch?

Day 1  closing & networking

Main stage - C1
Mar 26, 2026
5:05 PM5:15 PM

Day 1 Key take aways

B2B Area
Mar 26, 2026
5:15 PM7:00 PM

B2B meetings

Foyer
Mar 26, 2026
5:15 PM7:00 PM

Networking cocktail

Day 2 

Programme 27 March

Foyer
Mar 27, 2026
8:00 AM8:50 AM

Registration and breakfast

Main stage - C1
Mar 27, 2026
8:50 AM9:00 AM

Day 2 kick-off

Session 3: Usability of digital health solutions: Facilitating adoption today and tomorrow

Widespread adoption of digital medical devices will only happen if they serve their users, rather than adding administrative or practical burdens. This session highlights the importance of making devices intuitive, seamlessly embedded into clinical workflows and interoperable across electronic health records and hospital information systems to ensure their scalability and adoption. However, while AI-based devices have the potential to provide solutions for more efficient and better care, their adoption might require adapting workflows. We also discuss how to support the innovations of today while preparing users for the transformations of clinical and operational workflows of tomorrow.
Main stage - C1
Mar 27, 2026
9:00 AM9:15 AM

Rethinking usability: From convenience to key requirement

Main stage - C1
Mar 27, 2026
9:15 AM9:30 AM

Ensuring affordability for an effective, inclusive and sustainable adoption

Main stage - C1
Mar 27, 2026
9:30 AM10:20 AM

Round table - Adopting disruptive innovation for a healthy transformation of care: Are we ready?

Foyer
Mar 27, 2026
10:20 AM10:40 AM

Coffee break

Session 4:  Earning trust and unlocking market access: Gaining stakeholder confidence

The successful commercial launch of AI-driven digital medical devices requires trust. This session explores how to gain the confidence of key stakeholders — investors, clinicians, patients, regulators and payers — by clearly demonstrating the needs addressed, value, usability, accessibility and affordability of solutions. We also outline the key role of effective communication, marketing and training strategies that underpin a compelling and competitive business case ready for the EU market.
Main stage - C1
Mar 27, 2026
10:40 AM10:55 AM

Building trust: What are the key ingredients?

Main stage - C1
Mar 27, 2026
10:55 AM11:10 AM

Marketing, communication and training: necessary for digital medical device adoption?

Main stage - C1
Mar 27, 2026
11:10 AM12:00 PM

Round table - Innovation, regulation and competitiveness: How can Europe take the lead

Day 2  closing & networking

Main stage - C1
Mar 27, 2026
12:00 PM12:10 PM

Closing remarks

MD
Martine Deprez
Minister of Health and Social Security
B2B Area
Mar 27, 2026
12:10 PM2:00 PM

B2B meetings

Foyer
Mar 27, 2026
12:10 PM2:00 PM

Standing lunch